Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 33325051 | HLA (HLA) | autolysi | NA | NA | NA | unclassified | |
| we found initial evidence that antibodies against some antigens (autolysins: amd, gmd; secreted immunotoxins: chips, scin, hla) were associated with protection, while antibodies against the iron-regulated surface determinant (isd) proteins (isda, isdb, isdh) were aligned with adverse outcomes. | |||||||
| 33325051 | HLA (HLA) | autolysi | NA | NA | NA | unclassified | |
| we found initial evidence that antibodies against some antigens (autolysins: amd, gmd; secreted immunotoxins: chips, scin, hla) were associated with protection, whereas antibodies against the iron-regulated surface determinant (isd) proteins (isda, isdb, isdh) were aligned with adverse outcomes. | |||||||
| 30276649 | HLA-G (HLA-G) | neonatal deaths | NA | NA | NA | unclassified | |
| purpose of the reviewthis review highlights the role immune cells and markers such as natural killer (nk) cells, cytokines and human leukocyte antigen (hla-g) play in predisposing hiv-infected women who are on haart to develop pe, thus contributing to a better understanding and early diagnosis of pe with a subsequent reduction in maternal foetal and neonatal deaths.recent findingspregnant women infected with the human immunodeficiency virus (hiv) have a 25% risk of mother to child transmission. | |||||||
| 30739198 | HLA (HLA) | rs1297319 | Caucasian | rs118113626 | rs17219281 | unclassified | |
| NA | |||||||
| 30639295 | HLA (HLA) | ebola virus disease | NA | NA | NA | unclassified | |
| therefore, these peptides capable of inducing t and b cell response and being presented by a wide range of hla molecules have a strong potential to be part of diagnostic and preventive tools against ebola virus disease. | |||||||
| 33350932 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | ebola virus disease | NA | NA | NA | unclassified | |
| human diversity of killer cell immunoglobulin-like receptors and human leukocyte antigen class i alleles and ebola virus disease outcomes. | |||||||
| 33350932 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | ebola virus disease | NA | NA | NA | only_studied | |
| we studied the relationship between kir-human leukocyte antigen (hla) combinations and the clinical outcomes of patients with ebola virus disease (evd). | |||||||
| 30711607 | HLA (HLA) | pompe disease | NA | NA | NA | unclassified | |
| hla- and genotype-based risk assessment model to identify infantile onset pompe disease patients at high-risk of developing significant anti-drug antibodies (ada). | |||||||
| 30738281 | HLA-DR (HLA-DR) | nmo spectrum disorder | NA | NA | NA | unclassified | |
| the presence of risk allele hla-dr*03:01 may be an important genetic finding for familial nmo spectrum disorder patients. | |||||||
| 32093658 | HLA-DQB1 (HLA-DQB1) | rs3129753 | NA | rs464553 | rs1028883 | unclassified | |
| NA | |||||||
Copyright 2024